News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,800 Results
Type
Article (39688)
Company Profile (247)
Press Release (658865)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204164)
Career Advice (2007)
Deals (35417)
Drug Delivery (95)
Drug Development (81044)
Employer Resources (172)
FDA (16180)
Job Trends (14857)
News (345181)
Policy (32537)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49431)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (124)
Approvals (16185)
Artificial intelligence (253)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2256)
Cardiovascular disease (174)
Career advice (1676)
Career pathing (30)
CAR-T (151)
Cell therapy (422)
Cervical cancer (19)
Clinical research (65986)
Collaboration (832)
Compensation (533)
Complete response letters (19)
COVID-19 (2588)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2205)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6369)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86629)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112393)
Executive appointments (722)
FDA (17441)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (747)
Gene editing (104)
Generative AI (19)
Gene therapy (301)
GLP-1 (708)
Government (4416)
Grass and pollen (4)
Guidances (67)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16507)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (17)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13377)
Medtech (13382)
Mergers & acquisitions (19454)
Metabolic disorders (685)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1913)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (364)
Opinion (204)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57299)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20557)
Phase II (29056)
Phase III (21649)
Pipeline (1203)
Policy (138)
Postmarket research (2563)
Preclinical (8738)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22280)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (688)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (200)
Last 7 days (898)
Last 30 days (2626)
Last 365 days (32779)
2025 (10697)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37838)
Australia (6184)
California (6124)
Canada (2012)
China (523)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81240)
Florida (911)
Georgia (206)
Idaho (57)
Illinois (535)
India (25)
Indiana (307)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (894)
Massachusetts (4567)
Michigan (220)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1726)
New Mexico (28)
New York (1745)
North Carolina (966)
North Dakota (8)
Northern California (2680)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1375)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (23)
South Dakota (1)
Southern California (2299)
Tennessee (101)
Texas (906)
United States (23103)
Utah (180)
Virginia (145)
Washington D.C. (61)
Washington State (550)
West Virginia (3)
Wisconsin (54)
698,800 Results for "biodesix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
April 29, 2025
·
3 min read
Business
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is honored to announce it has been named to Inc. Magazine’s Best Workplaces list.
June 18, 2024
·
4 min read
Press Releases
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
March 4, 2025
·
11 min read
Press Releases
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
Press Releases
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
April 23, 2025
·
5 min read
BioMidwest
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
Biodesix, Inc. announced that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the 2024 RBCCM Global Healthcare Conference, which will be held from May 14-15, 2024.
May 7, 2024
·
3 min read
BioMidwest
Biodesix to Participate in Two Investor Conferences in June 2024
Biodesix, Inc., a leading diagnostic solutions company with a focus in lung disease, announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences.
May 28, 2024
·
1 min read
Press Releases
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 18, 2025
·
3 min read
Press Releases
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
January 8, 2025
·
5 min read
Press Releases
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
January 13, 2025
·
5 min read
1 of 69,880
Next
